Largest Lung Nodule Study: A Breakthrough for Diagnosis
In a retrospective pooled analysis of 1,100 patients with 4–30 mm noncalcified pulmonary nodules, the Nodify CDT blood-based autoantibody...
Patient Dosing Begins in Promising Phase II LSALT Peptide Trial
No drug-related adverse events have been assessed to date in Arch Biopartners’ Phase II trial of LSALT peptide for...
Hutchmed Starts Phase III Trial for B-Cell Lymphoma in China
A randomized, double-blind Phase II study of HMPL-760 plus R-GemOx in relapsed/refractory DLBCL reportedly improved ORR, CRR, PFS, and...
Beyond Cancer UNO Trial: Early Data Suggests Safety, Activity
Seven of ten patients remained alive 19–37 months after a single intratumoral injection of ultra‑high concentration nitric oxide (UNO)...
Rhythm Announces Topline Results for Phase 3 EMANATE Trial
EMANATE, a global Phase 3 study of setmelanotide across four heterozygous MC4R-pathway genetic subgroups, missed its primary endpoint of...
GNE Myopathy Research Advances Toward Phase I Clinical Trial
Preclinical data point to restored GNE protein expression and increased sialic acid production following intravenous delivery of a dual-function...
Transcon CNP Shows Durable Benefits in Achondroplasia Study
At Week 104 of the pivotal ApproaCH trial in children with achondroplasia, once-weekly TransCon CNP (navepegritide) maintained gains in...
Propanc & Fyonibio Launch Assay for Phase 1b Human Study
Propanc Biopharma has signed a services agreement with Berlin-based FyoniBio to develop and validate an LC-MS pharmacokinetics assay capable...
Aptorum, Diamir Publish microRNA Glioblastoma Biomarker Study
Aptorum Group and DiamiR Biosciences reported peer‑reviewed evidence that plasma microRNA signatures can detect glioblastoma, publishing feasibility findings in...
Polyrizon Launches GMP Manufacturing for U.S. Clinical Trial
Polyrizon has completed GMP manufacturing of clinical trial material for its lead intranasal hydrogel after two prior development batches...